Nivolumab+Ipilimumab
Sponsors
CoImmune, Dan Zandberg
Conditions
Advanced Renal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck
Phase 2
Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma
TerminatedNCT04203901
Start: 2020-07-22End: 2023-09-28Updated: 2023-10-02
Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
CompletedNCT04326257
Start: 2020-05-14End: 2024-08-12Updated: 2026-01-08